Pain and Chemical Dependency News
Friday and Saturday, March 18 & 19, 2011
8:00 AM - 4:00 PM
New York Marriott Marquis
New York, NY
Please join us at this CME symposium on the interface between pain and chemical
dependency, with its special emphasis on prescription drugs with abuse potential.
The goals of this conference are to provide the best evidence, the practical framework,
and the clinical guidelines necessary for the safe and effective use of opioids
and other controlled substances in pain management.
At the conclusion of this symposium, you will be able to:
- Evaluate the ongoing controversies regarding opioid therapy for nonmalignant pain, based
on evidence from randomized controlled trials and observational studies.
- Recognize the risks involved with prescription drug treatment – abuse, addiction and
diversion – and understand how to identify “at risk” patients.
- Determine what actions to take to structure and optimize treatment and manage
prescription drug abuse.
- Examine the interface between analgesia and addiction.
- Assess whether opioid therapy is appropriate for the management of pain in special
populations, and know the steps to take to optimize outcomes.
- Manage opioid side effects, and understand the risks of opioid-induced hyperalgesia and
methadone cardiac toxicity.
- Assess the use of abuse-deterrent opioids and cannabinoids.
- Evaluate the effectiveness of urine drug screening.
- Understand the current regulatory and legal climate, both local and federal, concerning
prescription of controlled substances, and the ongoing efforts to effect policy change.
Beth Israel Medical Center designates this educational activity for a maximum
of 13.25 AMA PRA Category 1 Credits™.
Read more: http://www.stoppain.org/for_professionals/content/education/education.asp
BACK |
